Current price is less than the intrinsic value

Intrinsic Value

Stock has been generating better return on equity than bank FD

ROE vs FD rates

Dividend Returns

Good time to consider, as stock is not in overbought zone

Entry Point

Stock not in ASM/GSM lists and not a lot of promoter holding is pledged

No Red Flags

Nureca stock hit a fresh low of Rs 525, down 2.48% against the previous close of Rs 538.35 on BSE. The stock opened lower at Rs 536 on BSE

Nureca shares hit all-time low after promoter sells stake

Shares of digital health and wellness company, Nureca, hit 52-week low at ₹525 after the promoter sold 55,863 shares at ₹546 apiece

Nureca share price hits 52-week low on bulk deal by promoter Payal Goyal

Shares of Nureca hit a 20-month low of Rs 562.50,down 3%, trading close to its record low of Rs 559.25 touched on March 19, 2021

Stock of this medical equipment company has tanked 74% so far in 2022

Nureca Consolidated September 2022 Net Sales at Rs 36.78 crore, down 21.64% Y-o-Y

Buzzing stocks: LIC, IDBI Bank, SBI, Atul Auto, Suzlon, Indraprastha Gas, JSW Steel, Veranda Learning, Ambuja Cements, Nureca, PowerGrid, Artsons

Stocks that will see action on October 10, 2022

Arshiya Ltd, Nureca Ltd, Deep Industries Ltd and Urja Global Ltd are among the other gainers in the BSE’s ‘B’ group today, 02 June 2022.

IZMO Ltd leads gainers in ‘B’ group

The Rs 100 crore IPO by Nureca rewarded investors the most, with a return of up to 323 per cent over the issue price of Rs 400. The company’s share sale offer was subscribed 40 times and it had listed at a premium of 59 per cent.

Multibagger IPOs: 15 debutants that delivered up to 300% return in 2021

Among the stock-specific action, Nureca, Cybertech Systems and India Glycols hit their upper circuits of 20 per cent each. Manaksia Aluminum and Jaiprakash Power Ventures topped in the losers pack on the back of profit booking.

Biggest gainers & losers of the day: Nureca, India Glycols, Cybertech zoom 20% each

HB Stockholdings Ltd, Supriya Lifescience Ltd, Shiva Mills Ltd and MSP Steel & Power Ltd are among the other gainers in the BSE’s ‘B’ group today, 29 December 2021.

Nureca Ltd leads gainers in ‘B’ group

Nureca shifts registered office

Nureca consolidated net profit declines 79.69% in the September 2021 quarter

Nureca Ltd is an India-based business to business (B2B) company engaged in the business of home healthcare and wellness products. It enables its customers with tools to help them in monitoring chronic ailments and other diseases to improve their lifestyle. The Company classifies its products portfolio under various categories, which include chronic device products, orthopedic products, mother and child products, nutrition supplements and lifestyle products. Its chronic device products include blood pressure monitors, pulse oximeters, thermometers, nebulizers, self-monitoring glucose devices, humidifiers and streamers. Its orthopedic products include rehabilitation products, such as wheelchairs, walkers and physiotherapy electric massagers. Its mother and child products include breast pumps, bottle sterilizers, bottle warmers and baby carry cots. Its nutrition supplements include fish oils, multivitamins, probiotics and vinegar.

Nureca Ltd

Nureca Ltd

Intrinsic Value
Intrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa

ROE vs FD rates
Fixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's long term average ROE is lower than this rate, investors are better off investing the amount in a FD

Dividend Returns
A dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company

Entry Point
High demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock

News & Opinions

Nureca shares hit all-time low after promoter sells stake

Nureca share price hits 52-week low on bulk deal by promoter Payal Goyal

Stock of this medical equipment company has tanked 74% so far in 2022

Nureca Consolidated September 2022 Net Sales at Rs 36.78 crore, down 21.64% Y-o-Y

Stocks that will see action on October 10, 2022

IZMO Ltd leads gainers in ‘B’ group

Multibagger IPOs: 15 debutants that delivered up to 300% return in 2021

Biggest gainers & losers of the day: Nureca, India Glycols, Cybertech zoom 20% each

Nureca Ltd leads gainers in ‘B’ group

Nureca Ltd

Intrinsic ValueIntrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa

ROE vs FD ratesFixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's long term average ROE is lower than this rate, investors are better off investing the amount in a FD

Dividend ReturnsA dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company

Entry PointHigh demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock

News & Opinions

Nureca shares hit all-time low after promoter sells stake

Nureca share price hits 52-week low on bulk deal by promoter Payal Goyal

Stock of this medical equipment company has tanked 74% so far in 2022

Nureca Consolidated September 2022 Net Sales at Rs 36.78 crore, down 21.64% Y-o-Y

Stocks that will see action on October 10, 2022

IZMO Ltd leads gainers in ‘B’ group

Multibagger IPOs: 15 debutants that delivered up to 300% return in 2021

Biggest gainers & losers of the day: Nureca, India Glycols, Cybertech zoom 20% each

Nureca Ltd leads gainers in ‘B’ group

Intrinsic Value
Intrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa

ROE vs FD rates
Fixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's long term average ROE is lower than this rate, investors are better off investing the amount in a FD

Dividend Returns
A dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company

Entry Point
High demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock